VivoPower PLC
NASDAQ Global MarketCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Tser Fah Chin
- Full Time Employees
- 92
- Sector
- Energy
- Industry
- Solar
- Address
- The Scalpel London United Kingdom EC3M 7AF
- IPO Date
- May 27, 2015
- CIK
- 0001681348
- Website
- vivopower.com
- Similar Companies
- Business
- Meridian Bioscience, Inc. is a fully integrated life science company that develops, manufactures, markets, and distributes a broad range of innovative diagnostic and life science products. The company's core offerings include diagnostic test kits, purified reagents, antibodies, antigens, specialty biologicals, and molecular and immunological reagents used in diagnostic applications. Meridian specializes in products for gastrointestinal and upper respiratory infections, blood lead level testing, parasitology, serology, and fungal disease diagnosis. It also supplies rare reagents and components for life science research, pharmaceutical, and biotech companies across more than 70 countries. Founded in 1976 and headquartered in Cincinnati, Ohio, Meridian serves a diverse customer base including hospitals, reference laboratories, research centers, physician offices, veterinary testing facilities, diagnostics manufacturers, and agri-bio companies. The company’s products are designed to deliver speed, accuracy, and simplicity in diagnostics, often requiring minimal equipment for use outside the human body. In recent developments, Meridian was acquired in a $1.53 billion all-cash transaction by a consortium led by SD Biosensor and SJL Partners, completed in early 2025. This strategic partnership leverages SD Biosensor’s R&D and mass production capabilities alongside Meridian’s U.S. market expertise to accelerate growth in the in vitro diagnostics (IVD) sector. Additionally, Meridian has appointed a new executive leadership team to drive global growth and innovation. The company also recently launched new animal-free immunoassay interference blockers, setting sustainability standards in diagnostic assay development. Meridian continues to expand its life science business through organic growth and acquisitions, including the integration of the Bioline group, which enhances its portfolio with nucleotides, PCR enzymes, and key global operations in the U.K., Germany, and Australia. Meridian Bioscience operates primarily in the medical equipment manufacturing industry, maintaining strong market positions in infectious disease diagnostics and life science research reagents, with a focus on global distribution and strategic innovation in diagnostics and life science materials. All information is current as of late 2025.
VivoPower taps ex-SpaceX battery engineer for AI data center advisory role
VivoPower Appoints SpaceX Veteran Porter Harris to Support AI Data Center Power and Battery Storage Strategy
VivoPower shortlists AI operator tenants for Norwegian data center
Critical Metals shares gain on 15-year rare earth offtake deal with REalloys
VivoPower Shortlists AI Tenants for 41.5MW Norway AI Data Center After Receiving Multiple Bids
Walmart shares drop as cautious outlook disappoints
VivoPower to join KBRA panel on AI infrastructure and data center capital markets
VivoPower CIO to Address Power Access and AI Infrastructure Financing at KBRA's European Data Centers Event in London
ON Holding Q1 earnings seen as potential catalyst for valuation re-rating, says UBS
VivoPower to Present at the Emerging Growth Conference
VivoPower to Present at the Emerging Growth Conference
VivoPower secures $1.9M EBITDA boost From Norway grid flexibility markets
VivoPower Targets $1.9 Million Annualized EBITDA Uplift from Enrollment of Norway Data Center into Statnett Reserve Markets Demand Response Program
VivoPower Targets $1.9 Million Annualized EBITDA Uplift from Enrollment of Norway Data Center into Statnett Reserve Markets Demand Response Program
VivoPower secures $1.9M EBITDA boost From Norway grid flexibility markets
VivoPower launches tenant search for Norwegian data center after acquisition
VivoPower Launches Lease Bidding after Receiving Strong Interest from AI Operators for 41.5MW Norway Data Center
VivoPower Launches Lease Bidding after Receiving Strong Interest from AI Operators for 41.5MW Norway Data Center
VivoPower launches tenant search for Norwegian data center after acquisition
Crocs faces balanced risk-reward into earnings as UBS flags mixed sentiment